Prospective Study on the Incidence of Postoperative Venous Thromboembolism in Korean Patients with Colorectal Cancer
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose Pharmacologic thromboprophylaxis is routinely recommended for Western cancer patients undergoing major surgery for prevention of venous thromboembolism (VTE). However, it is uncertain whether routine administration of pharmacologic thromboprophylaxis is necessary in all Asian surgical cancer patients. This prospective study was conducted to examine the incidence of and risk factors for postoperative VTE in Korean colorectal cancer (CRC) patients undergoing major abdominal surgery. Materials and Methods This study comprised two cohorts, and none of patients received perioperative pharmacologic thromboprophylaxis. In cohort A (n=400), patients were routinely screened for VTE using lower-extremity Doppler ultrasonography (DUS) on postoperative days 5-14. In cohort B (n=148), routine DUS was not performed, and imaging was only performed when there were symptoms or signs that were suspicious for VTE. The primary endpoint was the VTE incidence at 4 weeks postoperatively in cohort A. Results The postoperative incidence of VTE was 3.0% (n=12) in cohort A. Among the 12 patients, eight had distal calf vein thromboses and one had symptomatic thrombosis. Age ! 70 years (odds ratio [OR], 5.61), ! 2 comorbidities (OR, 13.42), and white blood cell counts of > 10,000/μL (OR, 17.43) were independent risk factors for postoperative VTE (p < 0.05). In cohort B, there was one case of VTE (0.7%). Conclusion The postoperative incidence of VTE, which included asymptomatic cases, was 3.0% in Korean CRC patients who did not receive pharmacologic thromboprophylaxis. Perioperative pharmacologic thromboprophylaxis should be administered to Asian CRC patients on a riskstratified basis.
Abstract
Purpose Pharmacologic thromboprophylaxis is routinely recommended for Western cancer patients undergoing major surgery for prevention of venous thromboembolism (VTE). However, it is uncertain whether routine administration of pharmacologic thromboprophylaxis is necessary in all Asian surgical cancer patients. This prospective study was conducted to examine the incidence of and risk factors for postoperative VTE in Korean colorectal cancer (CRC) patients undergoing major abdominal surgery. Materials and Methods This study comprised two cohorts, and none of patients received perioperative pharmacologic thromboprophylaxis. In cohort A (n=400), patients were routinely screened for VTE using lower-extremity Doppler ultrasonography (DUS) on postoperative days 5-14. In cohort B (n=148), routine DUS was not performed, and imaging was only performed when there were symptoms or signs that were suspicious for VTE. The primary endpoint was the VTE incidence at 4 weeks postoperatively in cohort A. Results The postoperative incidence of VTE was 3.0% (n=12) in cohort A. Among the 12 patients, eight had distal calf vein thromboses and one had symptomatic thrombosis. Age ! 70 years (odds ratio [OR], 5.61), ! 2 comorbidities (OR, 13.42), and white blood cell counts of > 10,000/μL (OR, 17.43) were independent risk factors for postoperative VTE (p < 0.05). In cohort B, there was one case of VTE (0.7%). Conclusion The postoperative incidence of VTE, which included asymptomatic cases, was 3.0% in Korean CRC patients who did not receive pharmacologic thromboprophylaxis. Perioperative pharmacologic thromboprophylaxis should be administered to Asian CRC patients on a riskstratified basis.
참고문헌 (25)
- Kim IG, "Deep vein thrombosis after surgery for gastrointestinal cancer: incidence and correlation with risk factors", J Korean Soc Vasc Surg, 20, pp.237~241 (2004)
- Kim JW, "A prospective study on the incidence of postoperative venous thromboembolism in Korean gastric cancer patients : an inquiry into the application of Western guidelines to Asian cancer patients", PLoS One, 8, pp.61968~ (2013)
- Shukla PJ, "Postoperative deep vein thrombosis in patients with colorectal cancer", Indian J Gastroenterol, 27, pp.71~73 (2008)
- Choi S, "Different characteristics and prognostic impact of deep-vein thrombosis", pulmonary embolism and intraabdominal venous thrombosis in colorectal cancer patients, 2011, pp.106, 1084~1094
- Weida D, "Is it safe to perform operation for colorectal malignancy in Chinese patients without DVT prophylaxis? An 8-year experience from a regional hospital in Hong Kong", Chin Med J(Engl), 123, pp.1973~1975 (2010)
- Yeo DX, "Incidence of venous thromboembolism and its pharmacological prophylaxis in Asian general surgery patients : a systematic review", World J Surg, 39, pp.150~157 (2015)
- Yhim HY, "Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database", J Thromb Haemost, 12, pp.1035~1043 (2014)
- Mandala M, "Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines", Ann Oncol, 22(Suppl 6), pp.85~92 (2011)
- Lyman GH, "Venous thromboembolism prophylaxis and treatment in patients with cancer : American Society of Clinical Oncology clinical practice guideline update", J Clin Oncol, 31, pp.2189~2204 (2013)
- Geerts WH, "Prevention of venous thromboembolism:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)", Chest, 133(6 Suppl), pp.381~453 (2008)
- 신애선, "Increasing Trend of Colorectal Cancer Incidence in Korea, 1999-2009", Cancer Research and Treatment, 44(4), pp.219~226 (2012), 대한암학회[DOI]
- Righini M, "D-Dimer for venous thromboembolism diagnosis : 20 years later", J Thromb Haemost, 6, pp.1059~1071 (2008)
- Simonneau G, "A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboem-bolism after colorectal surgery for cancer", J Thromb Haemost, 4, pp.1693~1700 (2006)
- Vedovati MC, "A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer", Ann Surg, 259, pp.665~669 (2014)
- Gould MK, "Prevention of VTE in nonorthopedic surgical patients : Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines", Chest, 141(2 Suppl), pp.227~277 (2012)
- Yang SS, "Symptomatic venous thromboembolism in Asian colorectal cancer surgery patients", World J Surg, 35, pp.881~887 (2011)
- Bergqvist D, "Venous thromboembolism : a review of risk and prevention in colorectal surgery patients", Dis Colon Rectum, 49, pp.1620~1628 (2006)
- Ay C, "Prediction of venous thromboembolism in cancer patients", Blood, 116, pp.5377~5382 (2010)
- Stender MT, "Preoperative plasma D-dimer is a predictor of postoperative deep venous thrombosis in colorectal cancer patients : a clinical, prospective cohort study with oneyear follow-up", Dis Colon Rectum, 52, pp.446~451 (2009)
- Cui G, "Incidence of postoperative venous thromboembolism after laparoscopic versus open colorectal cancer surgery : a meta-analysis", Surg Laparosc Endosc Percutan Tech, 23, pp.128~134 (2013)
- Kimura Y, "Incidence of venous thromboembolism following laparoscopic surgery for gastrointestinal cancer: a single-center, prospective cohort study", World J Surg (2015)[DOI]
- Sakon M, "Incidence of venous thromboembolism following major abdominal surgery : a multi-center, prospective epidemiological study in Japan", J Thromb Haemost, 4, pp.581~586 (2006)
- Lee FY, "Incidence of deep vein thrombosis after colorectal surgery in a Chinese population", ANZ J Surg, 71, pp.637~640 (2001)
- Cheung HY, "Risk of deep vein thrombosis following laparoscopic rectosigmoid cancer resection in chinese patients", Asian J Surg, 31, pp.63~68 (2008)
- Jang MJ, "Incidence of venous thromboembolism in Korea : from the Health Insurance Review and Assessment Service database", J Thromb Haemost, 9, pp.85~91 (2011)